BRANDON, Fla., Jan. 31, 2016 -- Brandon Eye Associates has purchased a Lumenis Selecta Duet Laser to treat glaucoma patients. According to the Glaucoma Foundation, up to 3 million Americans have glaucoma, but may be unaware as the disease can develop with few symptoms. The Lumenis Selecta Duet is an advanced anterior segment laser that combines YAG photo disruption with Selective Laser Trabeculoplasty (SLT) technology.
SLT uses single pulse, short duration lasers to treat glaucoma. Selective Laser Trabeculoplasty replaces the previous treatment, Argon Laser Trabeculoplasty. SLT uses a lower-power laser to focus a beam of light to treat the drainage angle of the eye.
Lawrence C. Taylor Jr., M.D., of Brandon Eye Associates, believes this laser will enable them to offer better care for their patients who suffer from glaucoma. "Glaucoma is a condition in which pressure increases in the eyeball, eventually causing blindness. During a comprehensive eye exam, we perform several tests that screen for glaucoma, including an eye pressure test, peripheral vision tests, and a physical examination of the eye itself. When glaucoma is caught early, we can begin treatment that will help slow the rate in which vision loss occurs," stated Dr. Taylor.
Glaucoma is treated with eye drops, medications, and laser surgery. Trabeculoplasty is the most common type of laser surgery in the treatment of glaucoma. The laser is focused on the eye's drain and causes subtle changes allowing the aqueous fluid to pass more easily out of the drain.
According to Dr. Taylor, "Laser surgery is a great treatment option for our glaucoma patients. They can generally go home and return to normal activities within just a few hours. With our new Selecta Duet laser, we are able to provide very precise laser treatments in our office. It has several advanced features which allow us not only treat glaucoma, but also posterior capsule opacity, which is a condition that can occur after cataract surgery."
Glaucoma has no cure and is a leading cause of blindness if left untreated. Even with treatment, up to 10 percent of those diagnosed will experience some degree of vision loss. Individuals of every race and age are at risk of developing glaucoma. However, those who are diabetic or extremely nearsighted are at greater risk for developing blindness as a result of glaucoma.
Brandon Eye Associates has two locations: 540 Medical Oaks Avenue, Suite 103, Brandon, FL 33511 and 105 Southern Oaks Drive, Plant City, FL 33563. To make an appointment or to inquire about services, contact them at 813-666-8302. Their office hours are from 8:00 AM to 12:00 Noon, and from 1:00 PM to 5:00 PM, Monday through Friday. For more information, visit them online at www.brandoneyeassociates.com.
Brandon Eye Associates, 813-666-8302


Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 



